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ABSTRACT
Background. Among people treated for hypertension, the pres-
ence of elevated blood pressure (BP) out of the clinic but normal
BP in the clinic is called masked uncontrolled hypertension
(MUCH). What causes MUCH remains unknown. The purpose
of this study was to answer the question of whether patients
withMUCH have an increased hemodynamic reactivity to exer-
cise and delayed hemodynamic recovery following exercise.
Methods. Four groups were compared: controlled hypertension
(CH, n ¼ 58), MUCH (n ¼ 34) and uncontrolled hypertension
(UCH, n¼ 12), all of which had chronic kidney disease (CKD),
and a group of healthy normal volunteers who did not have
hypertension or CKD (n ¼ 16). All participants underwent
assessment of 24-h ambulatory BP monitoring, BP measure-
ment during a graded symptom-limited exercise using a cycle
ergometer and BP recovery over 7 min following exercise.
Results. Exercise-induced increase in systolic BP was similar
among the four groups. When compared with healthy controls,
recovery of systolic BP following termination of exercise was
blunted among the CKD groups in unadjusted (P < 0.0001)
and adjusted (P < 0.001) models. During recovery, the healthy
control group had 5.9% decline in systolic BP per minute. In
contrast, MUCH had only 3.3% per minute reduction and the
UCH group had 0.3% reduction per minute. A test of linear
trend was significant (P¼ 0.002, adjusted model).
Conclusion. Because there was no impairment in the heart rate
recovery among groups, we speculate that the parasympathetic
pathway appears intact among treated hypertensives with CKD.
However, the failure to withdraw sympathetic tone upon termi-
nation of exercise causes ongoing vasoconstriction and delayed
systolic BP recovery providing a biological basis for MUCH.
Delayed recovery from exercise-induced hypertension in those
with poorly controlled BP provides potentially a new target to
assure round-the-clock BP control.
Keywords: ambulatory blood pressure monitoring, chronic
kidney disease, exercise, recovery, systolic blood pressure
INTRODUCTION
It has long been recognized that both heart rate and systolic
blood pressure increase with physical activity and are risk fac-
tors for the future development of hypertension [1–4]. This
activity-induced change in heart rate and systolic BP are impor-
tant determinants of myocardial oxygen demand and, in those
with obstructive coronary artery disease, may trigger myocar-
dial ischemia. It is also well recognized that masked hyperten-
sion and masked uncontrolled hypertension (MUCH) is
associated with increased cardiovascular risk [5–9]. Whether
this elevated cardiovascular risk is due to a more robust vascular
reactivity is unknown. If those with MUCH have an increased
systolic BP and heart rate response to exercise, it may shed light
on the pathophysiology of MUCH.
During rest, following a bout of physical activity, withdrawal
of sympathetic tone and increase in parasympathetic activity
allows BP and heart rate to return to baseline. The diagnosis of
MUCH requires measurement of ambulatory BP—the diagnosis
is made among treated hypertensives when ambulatory BP is ele-
vated but clinic BP is normal [10]. It is therefore possible that
MUCH is associated with a more persistent sympathetic tone
and delayed recovery of systolic BP following a bout of exercise.
This has not been previously reported, but if this notion is correct
it would contribute to our understanding of the pathophysiology
of MUCH and its association with increased cardiovascular risk.
In this study, we test the hypothesis that patients with
MUCH have an exercise-induced hypertensive response that
has an intermediate phenotype, i.e. the hypertensive response in
MUCH is more than those with controlled hypertension (CH)
but less than those with uncontrolled hypertension (UCH).
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|Furthermore, we test the notion of whether those with MUCH
have recovery of BP and heart rate after a bout of exercise that is
slower than those with CH and better than those with UCH.
Accordingly, the overarching aim of this study was to answer
the question of whether patients with MUCH have an increased
hemodynamic reactivity to exercise and delayed hemodynamic
recovery following exercise.
MATERIALS AND METHODS
Participants
This is a prospective study of chronic kidney disease (CKD)
patients Stages 2–4 [estimated glomerular filtration rate (GFR)
defined using the modification of diet in renal disease equation
<90 mL/min/1.73 m2 but >15 mL/min/1.73 m2]. For those
with Stage 2 CKD, albuminuria (A2 or >300 mg/g creatinine)
was required for inclusion in the cohort. Those with an initial
clinic BP of 140/90 mmHg or less were considered eligible and
studied further. Participants with recent hospitalization, use of
home oxygen, inability to ride a stationary bicycle due to dis-
ability or a recent cardiovascular event were excluded. Detailed
inclusion and exclusion criteria have been previously published
[11]. The study was approved by the Institutional Review Board
of Indiana University and the Research and Development
Committee of the Roudebush Veterans Administration Medical
Center, Indianapolis. All study participants provided written
informed consent.
Classification of groups
Four groups were compared in this report: CH, MUCH,
UCH and a group of healthy normal volunteers who did not
have hypertension or CKD. The latter also were Veterans, all
>50 years of age, non-smokers, had no diabetes mellitus and
did not have pre-existing cardiovascular disease. The diagnostic
criteria for the diagnosis of hypertension have been previously
published [11]. Briefly, thresholds of BP to define hypertension
were 140/90 in the clinic and 135/85 mmHg using daytime
ambulatory BP. MUCH was diagnosed in those who had con-
trolled clinic BP (<140/90 mmHg on average of three clinic vis-
its by oscillometric BP measurement) but elevated ambulatory
BP. CH required BP below the thresholds and UCH above the
thresholds both in the clinic and outside. White coat hyperten-
sion was not studied.
Protocol for exercise and BP measurements
Participants were familiarized with the instruments and pro-
cedures were generally carried out in a fasting state in the morn-
ing. Subjects mounted an electronically braked cycle ergometer
(Corival, Lode, Groningen, The Netherlands). Following meas-
urement of three baseline blood pressures at 1 min intervals
(Tango M2, Suntech), a ramped symptom-limited maximal test
was performed. Exercise was started at 20 W/min and was
increased by 20 W/min every 3 min. Every minute after the
onset of exercise we monitored the auscultatory BP and the sub-
jective feeling of shortness of breath and exercise intensity using
the Borg scale. All participants were instructed to stop exercise
immediately if they experienced dizziness or chest pain. The
reason for stopping the exercise was recorded.
After the end of exercise, subjects were transferred to a flat
bed and monitored for another 7 min. During this time, BP and
heart rate were measured.
Blood pressure was recorded with an automated auscultatory
device with EKG gating (TangoM2, Suntech). Exercise bike was
electronically braked to give a consistent work-rate at a cadence
of>30 r.p.m. Participants were asked to pedal at60 r.p.m.
Data analysis
Baseline characteristics among groups were compared using
one-way ANOVA for continuous variables and v2 test for dis-
crete variables. Hemodynamic variables during exercise (BP
and heart rate) were regressed over exercise intensity to calcu-
late slopes for each individual. Box plots over groups were cre-
ated to display results. Given the negative exponential rate of
recovery following the termination of exercise, natural logs of
BP and heart rate were regressed over time to calculate recovery
slopes and plotted in a similar fashion as above.
A linear mixed model was used to estimate slopes of hemo-
dynamic response and exercise relationship (as shown Table 2)
[12]. In this model, the outcome was either BP (systolic or dia-
stolic) or heart rate. The predictor variables were the group clas-
sification (normal, CH, MUCH, UCH) as indicator variables,
exercise intensity in watts as continuous variable and interac-
tion of the two terms. A random coefficient model was used
with subject and time of exercise as random variables and cova-
riance was modeled as unstructured; estimation algorithm was
that of maximal likelihood. Multivariable adjustments were
then made for the following variables: age, race, body mass
index, hemoglobin, albumin, estimated GFR, natural log of the
urine albumin/creatinine ratio in the overnight specimen and
the number of antihypertensive medications. We also adjusted
the model for interaction terms for each of these covariates with
exercise intensity (two-way interactions) and group classifica-
tions (three-way interactions). Baseline presence of cardiovas-
cular disease and diabetes mellitus are likely in the causal
pathway for hemodynamic response and therefore not adjusted
for in Model 2. However, Model 3 was further adjusted for dia-
betes mellitus and cardiovascular disease defined as past myo-
cardial infarction, stroke or hospitalization for congestive heart
failure.
A mixed model was used to model slopes of hemodynamic
response and recovery relationship (as shown in Table 3). In
this model, the outcome was either BP (systolic or diastolic) or
heart rate. Given the negative exponential rate of recovery, each
of these variables was natural log transformed prior to model
fitting. The predictor variables were the group classification
(normal controls, CH, MUCH, UCH) as indicator variables,
time since end of exercise in minutes as a continuous variable
and interaction of the two terms. A random coefficient model
was used with subject and time of exercise as random variables
and covariance was modeled as unstructured with maximal
likelihood estimation.
In each of the mixed models noted above, the unadjusted
results are shown as Model 1. Model 2 shows multivariable
adjusted results for the variables noted above. Model 3 was
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|further adjusted for diabetes and cardiovascular disease. Each of
these variables completely interacted with recovery time and BP
classification to examine not only the influence of these terms
on the intercepts but also the slopes.
To examine the influence of systolic BP recovery after exer-
cise in relation to b-blocker use, a similar mixed model was
used. b-Blocker term was interacted with the group classifica-
tion recovery time term. Marginal means were calculated per
minute of recovery among users and non-users of b-blockers
(as shown in Figure 4). A similar model was used to estimate
marginal means of systolic BP recovery in relationship to ische-
mia (see Figure 5). All analyses were carried out using Stata 14.1
(Stata Corp, College Station, TX, USA).
RESULTS
Table 1 shows the baseline characteristics of the study sample.
Of the 21 healthy subjects evaluated in this study, 4 were found
to have masked hypertension and 1 hypertension and therefore
excluded from the control group; the table shows the 16 truly
normotensive controls. Age, sex, weight and body mass index
were well matched but as expected there were more blacks
among those with CKD. Mean estimated GFR averaged 33–35
mL/min/1.73 m2 in those with CKD. The median urinary albu-
min/creatinine ratio was <0.01, 0.02, 0.04 and 0.22 g/g in con-
trols, CH, MUCH and UCH groups, respectively.
Figure 1 shows the mean observed hemodynamic responses
among groups during exercise (top row) and recovery (bottom
row). The hemodynamic response during exercise (Figure 1A–
C) is plotted against exercise intensity which was ramped every
3 min, whereas the recovery (Figure 1D–F) is plotted as minutes
elapsed after the end of exercise.
The slopes of hemodynamic response during exercise are
shown in Figure 2. Since b-blockers can be reasonably expected
to influence hemodynamic responses during exercise, data in
the bottom graphs are dichotomized by b-blocker use. The
slopes of hemodynamic recovery after exercise are shown in
Figure 3. Data were log transformed to reflect the exponential
nature of the recovery. The bottom three graphs are stratified by
b-blocker use.
Table 2 shows the slopes of hemodynamic changes during
exercise compared with the control group using a mixed model.
Model 1 shows the unadjusted results. Model 2 shows multi-
variate adjusted results for the variables noted in the materials
and methods section. For the outcome of systolic BP, the overall
interaction effect of hypertension classification  exercise
intensity was not significant (P ¼ 0.31 in unadjusted model, P
¼ 0.12 in adjusted model). Thus, systolic BP response was simi-
lar among groups, as were other hemodynamic responses.
Model 3 was further adjusted for diabetes and cardiovascular
disease. The overall interaction effect of hypertension classifica-
tion exercise intensity remained non-significant (P¼ 0.08).
To investigate the independent effect of b-blocker use on
hemodynamic response to exercise, Model 1 was further
adjusted for b-blocker use. No statistical significance was found
between the use of b-blocker and BP response to exercise (P-
values systolic BP¼ 0.33 and diastolic BP¼ 0.10). Resting heart
rate was lower among users of b-blockers (P ¼ 0.02); however,
the increment in heart rate was not influenced by b-blocker use
Table 1. Clinical characteristics of the study sample
Clinical characteristic Control Controlled
hypertension
Masked uncontrolled
hypertension
Uncontrolled
hypertension
P-value
Number of participants 16 58 34 12
Age (years) 66.56 6.6 71 6 9.4 69.16 10.2 68.26 12.4 0.38
Male sex 15 (93.8%) 58 (100%) 34 (100%) 12 (100%) 0.09
Whites 15 (93.8%) 49 (84.5%) 22 (64.7%) 8 (66.7%) 0.01
Blacks 1 (6.3%) 9 (15.5%) 12 (35.3%) 3 (25%)
Asians 0 (0%) 0 (0%) 0 (0%) 1 (8.3%)
Weight (kg) 85.46 15.7 91.4 6 18.8 88.56 15.1 83.76 21.1 0.42
Body mass index (kg/m2) 27.56 3.9 30.2 6 5.2 28.86 4.6 28.96 6 0.25
Waist circumference (cm) 102.16 11.1 110.66 13.8 106.56 12.0 103.66 14.1 0.07
Hip circumference (cm) 102.66 6.7 106.66 10.8 103.46 8.7 100.26 11.9 0.13
Waist–hip ratio 0.996 0.07 1.04 6 0.06 1.036 0.06 1.036 0.08 0.16
Current tobacco use 0 (0%) 9 (15.5%) 12 (35.3%) 2 (16.7%) 0.02
Diabetes mellitus 0 (0%) 35 (60.3%) 20 (58.8%) 9 (75%) <0.0001
Myocardial infarction 0 (0%) 17 (29.3%) 8 (23.5%) 4 (33.3%) 0.09
Stroke 0 (0%) 5 (8.6%) 4 (11.8%) 1 (8.3%) 0.58
Congestive heart failure 0 (0%) 8 (13.8%) 5 (14.7%) 4 (33.3%) 0.1
Systolic BP (mmHg) 116.66 9.6 113.96 11.6 126.56 7.8 152.16 14.9 <0.0001
Diastolic BP (mmHg) 68.36 7.7 59.9 6 8.1 64.16 8.7 71.76 18.2 <0.001
Pulse rate 65.36 7.9 66.2 6 11.4 64.46 11.3 62.66 11.9 0.73
Number of BP medications 0.16 0.3 2.6 6 1.5 2.76 1.6 2.56 1.9 <0.0001
b-Blocker use 0 (0%) 37 (63.8%) 22 (64.7%) 9 (75%) <0.0001
ACE inhibitor or ARB use 0 (0%) 34 (58.6%) 15 (44.1%) 5 (41.7%) <0.001
Estimated GFR (mL/min/1.73 m2) 78.36 17.7 35 6 11.4 34.96 13.8 33.26 14.9 <0.0001
Log urinary albumin/creatinine ratio (g/g) 5.76 0.6 3.6 6 1.8 2.76 2.5 26 2.5 <0.0001
Serum albumin (g/dL) 3.96 0.4 3.8 6 0.3 3.86 0.3 3.96 0.6 0.75
Hemoglobin (g/dL) 14.86 1.3 13.4 6 1.6 13.36 1.8 13.36 2.1 0.03
Data are presented as mean 6 standard deviation, or n (%).
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|(P ¼ 0.19 for slope differences compared with b-blocker non-
users).
When compared with healthy controls, unadjusted models
showed that recovery of systolic BP (P < 0.0001) and heart
rate (P ¼ 0.02), but not diastolic BP (P ¼ 0.11), was blunted
among the CKD groups (Table 3). Multivariable adjustments
did not remove the statistical significance of systolic BP recov-
ery (P < 0.001), did not change the statistical significance of
diastolic BP recovery (P ¼ 0.11) and removed the significance
of heart rate recovery (P ¼ 0.22). The coefficients in Table 3
noted are approximately the percent change per minute of
recovery. Thus, the control group has 5.9% decline in systolic
BP per minute. In contrast, CH and MUCH groups had only
3.3% per minute reduction and the UCH group had 0.3%
reduction per minute. Thus, the UCH group had no notable
change in systolic BP recovery over the 7 min of recovery. A
test of linear trend was highly significant (P < 0.0001) in
unadjusted model and significant (P < 0.001) in the adjusted
models (Models 2 and 3). Thus, systolic BP recovery followed
the trend healthy>CH>MUCH>UCH. In comparison, dia-
stolic BP recovery was similar among groups (P > 0.10 for
each of the three models). Heart rate recovery was different
among groups in the unadjusted model (P ¼ 0.02) but was
similar following adjustments (P ¼ 0.22, Model 2 and
P¼ 0.29, Model 3).
Figure 4 shows that b-blocker significantly blunted the
recovery in systolic BP (P ¼ 0.004 for b-blocker  systolic BP
recovery interaction). This was not the case for either diastolic
BP (P¼ 0.5) or heart rate (P¼ 0.17). To investigate further the
reason for delayed systolic BP recovery, the reasons for stopping
exercise were explored. Participants who exercised to exhaus-
tion served as a comparator group to those who stopped exer-
cising because of leg pain, leg fatigue or shortness of
breath. Those who experienced shortness of breath were not
tired or exhausted but had to stop because of the unpleasant
sensation due to dyspnea. For these analyses, for the sake of
convenience we classify these two groups as absence or presence
of ischemia.
Figure 5 shows that ischemia significantly impaired the
recovery of systolic BP after exercise in both the adjusted (P ¼
0.006) and unadjusted models (P ¼ 0.007). Exercise was termi-
nated due to ischemia for only 3 (19%) in the healthy controls
group, but in 21 (36%) in CH, 13 (38%) in MUCH and 6 (50%)
in UCH. Exercise was terminated because of exhaustion in 29
(50%) in CH, 19 (56%) in MUCH, 5 (42%) in UCH and 12
(75%) in controls. In the remaining 12 participants, exercise
FIGURE 1: Mean hemodynamic responses by blood pressure (BP) classification status. (A–C) Response during exercise as a function of sta-
tionary bicycle exercise measured in watts. The baseline measurement is a mean of three at rest when exercise intensity is zero. Hemodynamic
responses are an average of three measurements at each level of exercise. Each level of exercise was maintained for 3 min before being escalated
to the next level. The I bars are 10th and 90th percentile of values at that level. After exercise, the participant was immediately placed supine in
bed. (D–F) The changes following termination of exercise. Time zero reflects the response just before rest in that individual following which
measurements were made at each of the seven minutes. The first plotted value in (D) does not match the last plotted value of (A) because par-
ticipants terminated exercise at varying times. The last value prior to rest is what is plotted in (D). CH, controlled hypertension; MUCH,
masked uncontrolled hypertension; UCH, uncontrolled hypertension.
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FIGURE 3: Box plots of hemodynamic recovery slopes by blood pressure (BP) classification status. SBP, systolic BP; DBP, diastolic BP; HR,
heart rate; H, healthy controls; CH, controlled hypertension; MUCH, masked uncontrolled hypertension; UCH, uncontrolled hypertension.
(A–C) Overall recovery response. (D–F) Responses stratified by b-blocker use. 0 represents no b-blocker use and 1 represents the prescription
of the drug.
FIGURE 2: Box plots of hemodynamic slopes during exercise by blood pressure (BP) classification status. SBP, systolic BP; DBP, diastolic BP;
HR, heart rate; H, healthy controls; CH, controlled hypertension; MUCH, masked uncontrolled hypertension; UCH, uncontrolled hyperten-
sion. (A–C) Overall exercise response. (D–F) Exercise responses stratified by b-blocker use where 0 represents no b-blocker use and 1 repre-
sents the prescription of the drug. No healthy volunteers were on b-blockers. The box represents 25th and 75th percentiles, the clear horizontal
bar in the box is the median. The error bars are upper and lower adjacent values and dots the values that lies outside these ranges. Since exercise
was incremented by 20 W every 3 min, data shown are changes in each of the hemodynamic parameter per 20 W. Thus, BP changes are
mmHg per 20 W increment in exercise. HR changes are beats per minute change per 20 W increment in exercise.
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was stopped due to arthritic pain or discomfort from the seat of
the cycle with distribution as follows: 8 (14%) in CH, 2 (6%) in
MUCH, 1 (8%) in UCH and 1 (6%) in the control group. Data
shown are after dropping the 12 participants who stopped the
exercise early due to miscellaneous reasons. Including the 12
participants in the third category did not significantly alter the
statistical significance of the results.
DISCUSSION
The hypothesis tested in this report was that heightened BP
reactivity to exercise is an important cause that underscores the
pathophysiology of masked hypertension. Accordingly, those
with MUCH were compared with three other groups: CH,
UCH and healthy controls. We did not find any differences
among groups in pressor or chronotropic response to exercise.
Numerically, the systolic BP–exercise relationship was nearly
twice in those with MUCH as in CH. However, the statistical
significance wasmarginal (P¼ 0.07) and disappeared after mul-
tivariable adjustments. Even small differences were not seen in
heart rate response or diastolic BP among groups. Furthermore,
pressor or chronotropic responses in the groups with CKD were
similar to age-matched controls without CKD or hypertension.
Perhaps a larger study may be able to detect smaller differences
but the results of this study suggest that exercise-induced
Table 2. Mixed model derived slope estimates during exercise
Variable Model 1 Model 2 Model 3
Estimate P-value Estimate P-value Estimate P-value
Healthy controls
Systolic BP 4.27 6 1.5 <0.01
Diastolic BP 0.01 6 0.6 0.99
Heart rate 5.76 0.88 <0.0001
Controlled hypertension
Systolic BP 3.25 6 0.93 <0.001 2.84 6 1.35 0.03 2.93 6 1.35 0.03
Diastolic BP 0.77 6 0.35 0.03 0.51 6 0.45 0.26 0.49 6 0.45 0.27
Heart rate 7.99 6 0.53 <0.0001 8.16 6 0.73 <0.0001 8.03 6 0.74 <0.0001
Masked uncontrolled hypertension
Systolic BP 6.09 6 1.18 <0.0001 6.24 6 1.61 <0.001 6.44 6 1.64 <0.0001
Diastolic BP 0.26 6 0.45 0.56 0.72 6 0.55 0.19 0.79 6 0.55 0.15
Heart rate 6.13 6 0.68 <0.0001 6.18 6 0.9 <0.0001 6.25 6 0.91 <0.0001
Uncontrolled hypertension
Systolic BP 3.86 6 2.05 0.06 2.14 6 4.01 0.59
Diastolic BP 0.01 6 0.78 0.99 0.4 6 1.36 0.77
Heart rate 7.66 6 1.17 <0.0001 7.79 6 2.15 <0.001
The P-values test the hypothesis of slopes within group being 0 and 6 are standard errors of estimates. Healthy controls do not have adjusted information because they were not on
antihypertensive agents and they did not have albuminuria, covariates that were adjusted for in other groups. Nonetheless, if adjustments were made, the coefficients became unstable.
Model 2 is multivariate adjusted for the following variables: age, race, body mass index, hemoglobin, serum albumin, estimated glomerular filtration rate, log of urinary albumin/creati-
nine ratio and the number of blood pressure (BP) medications. Model 3 is further adjusted for diabetes mellitus and cardiovascular disease (myocardial infarction, stroke or congestive
heart failure). Model 3 does not have estimates shown for uncontrolled hypertension due to them being unstable. The unit for estimates for BP are mmHg/20 watts exercise and fr heart
rate b.p.m/20 watts exercise.
Table 3. Mixed model derived slope estimates during recovery
Variable Model 1 Model 2 Model 3
Estimate P-value Estimate P-value Estimate P-value
Healthy controls
Systolic BP 0.0596 0.006 <0.0001
Diastolic BP 0.0126 0.005 0.06
Heart rate 0.0556 0.004 <0.0001
Controlled hypertension
Systolic BP 0.0336 0.003 <0.0001 0.0366 0.003 <0.0001 0.0366 0.003 <0.0001
Diastolic BP 0.0036 0.003 0.27 0.0066 0.003 0.06 0.0066 0.003 0.05
Heart rate 0.05 6 0.002 <0.0001 0.056 0.002 <0.0001 0.05 6 0.002 <0.0001
Masked uncontrolled hypertension
Systolic BP 0.0336 0.004 <0.0001 0.0376 0.004 <0.0001 0.0376 0.004 <0.0001
Diastolic BP 0.0016 0.004 0.7 0.0036 0.004 0.34 0.0036 0.004 0.34
Heart rate 0.0486 0.003 <0.0001 0.0496 0.003 <0.0001 0.0496 0.003 <0.0001
Uncontrolled hypertension
Systolic BP 0.0036 0.007 0.7 0.0056 0.007 0.53 0.0066 0.007 0.43
Diastolic BP 0.01 6 0.006 0.12 0.0126 0.006 0.07 0.01 6 0.006 0.1
Heart rate 0.0376 0.005 <0.0001 0.0396 0.005 <0.0001 0.04 6 0.005 <0.0001
The P-values test the hypothesis of slopes within group being 0 and 6 are standard errors of estimates. Healthy controls do not have adjusted information because they were not on
antihypertensive agents and they did not have albuminuria, covariates that were adjusted for in other groups. Nonetheless, if adjustments were made, the coefficients became unstable.
Models 2 and 3 are as described in the legend of Table 2. BP, blood pressure.
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changes in BP are not important in the pathophysiology of
MUCH in CKD.
The major finding of this study was that systolic BP recovery
after termination of exercise was delayed; this is important and
requires an explanation. The normal response to termination of
exercise is an increase in parasympathetic tone and a reduction
in sympathetic tone. This allows the heart rate and BP to return
to baseline. There was no impairment in the heart rate recovery
among groups, thus the parasympathetic pathway appears
intact among treated hypertensives with CKD. The failure to
withdraw sympathetic tone would cause ongoing vasocon-
striction and delayed systolic BP recovery. CKD is a state of
sympathetic hyperactivity [13, 14] and ischemia can further
trigger sympathetic activation [15, 16]. Consistent with this
hypothesis is the observation that b-blocker use that is associ-
ated with heightened vasoconstriction was associated with a
further impairment in systolic BP recovery (Figure 4).
Furthermore, in those participants who stopped not because
of exhaustion due to maximal exercise but due to leg pain or
shortness of breath proxies for impaired peripheral oxygena-
tion; there was also impairment in systolic BP recovery. A
highly significant linear relationship was noted among the
progressively increasing hypertension categories (moving
from healthy, CH, MUCH and to UCH) and delayed systolic
BP recovery. This suggests that withdrawal of sympathetic
tone may be important for the pathophysiology of MUCH.
Endothelial function was not directly measured so it is dif-
ficult to exclude this as a cause of the delayed systolic BP
recovery. It is possible that endothelial dysfunction can cause
failure of vasorelaxation after the termination of exercise; but
this is less likely the explanation for the observations. One
would expect that if endothelial dysfunction was the sole
explanation of these findings, the systolic BP response during
exercise should have been steeper in those with CKD. This
was however not the case. Future studies will examine the role
of endothelial dysfunction and its relationship with delayed
systolic BP recovery since endothelial function is known to be
impaired during sympathetic activation [17].
The study was relatively small and predominantly per-
formed in older men. Whether our findings translate to
younger people and women remains to be seen. There is at
least some evidence that an elevated post-exercise BP is a pre-
dictor of the future development of hypertension [18]. Nearly
all participants with hypertension were treated. Whether our
results apply to those with untreated hypertension will require
future studies. There are several strengths of our study. We
used 24-h ambulatory blood pressure monitoring to diagnose
out-of-office hypertension. This is the gold-standard against
which other methods are measured and it provides the most
accurate classification based on out-of-office BP control. A
formal exercise testing protocol was used for all participants
and one physician performed all the measurements. This
likely increases the precision of the results, especially as it
relates to uncovering the pathophysiology of MUCH.
In summary, although we did not find increased hemody-
namic reactivity among those with MUCH and CKD, the
delayed systolic BP recovery following exercise related to the
hypertension categories among those with CKD is a novel dis-
covery. The delayed systolic BP recovery had a graded rela-
tionship with increasing severity of hypertension even after
multivariable adjustment. In those who had UCH, systolic BP
remained elevated persistently over the 7 min of recovery. This
suggests that whereas the stationary component of hypertension
may be important for target organ damage among those with
hypertension, more attention should be paid to understand the
mechanisms and methods to mitigate the delayed recovery
from exercise-induced hypertension in those with poorly
FIGURE 5: Effect of ischemia as reason for stopping exercise on sys-
tolic blood pressure (BP) recovery. The slope estimates from mixed
model are plotted for healthy controls, controlled hypertension
(CH), masked uncontrolled hypertension (MUCH) and uncontrolled
hypertension (UCH). The I bars indicate standard error of the mean.
Ischemia is indicated as no or yes across the groups. In contrast to
exhaustion or maximal exercise, ischemia was defined as leg pain, leg
fatigue or shortness of breath as the reason for stopping exercise.
Ischemia significantly impaired the recovery of systolic BP after exer-
cise in both the adjusted (P ¼ 0.006) and unadjusted models (P ¼
0.007).
FIGURE 4: Effect of b-blocker use on systolic blood pressure (BP)
recovery. The slope estimates from mixed model are plotted for
healthy controls, controlled hypertension (CH), masked uncontrolled
hypertension (MUCH) and uncontrolled hypertension (UCH). The I
bars indicate standard error of the mean. b-Blocker use is indicated
as no or yes across the groups. No healthy participant was on any
antihypertensives so the slope estimates are absent. b-Blocker use
significantly impaired the recovery of systolic BP after exercise in
both the adjusted (P ¼ 0.004) and unadjusted models (P ¼ 0.004).
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|controlled BP. This may provide strategies to better diagnose
and manage hypertension. The occurrence of delayed systolic
recovery following exercise in MUCH provides further evidence
for a biological basis for MUCH.
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